Page last updated: 2024-10-27

fluoxetine and Adrenal Cancer

fluoxetine has been researched along with Adrenal Cancer in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montastruc, JL1
Chamontin, B1
Senard, JM1
Tran, MA1
Rascol, O1
Llau, ME1
Rascol, A1
Sheps, SG1
Rummans, TA1

Other Studies

2 other studies available for fluoxetine and Adrenal Cancer

ArticleYear
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
    Lancet (London, England), 1993, Feb-27, Volume: 341, Issue:8844

    Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Diagnosis, Differential; Drug Interactions; Female;

1993
Fluoxetine's effect on biochemical screening for pheochromocytoma.
    American journal of hypertension, 1996, Volume: 9, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Female; Fluoxetine; Humans; Male; Middle Aged;

1996